benzylamine has been researched along with Alloxan Diabetes in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Carpéné, C; Iffiú-Soltesz, Z; Szökő, É; Tóthfalusi, L; Wanecq, E | 1 |
| Bour, S; Carpéné, C; Garcia-Barrado, MJ; Iglesias-Osma, MC; Moratinos, J; Pastor-Mansilla, MF; Prévot, D; Valet, P; Visentin, V | 1 |
| Boucher, J; Bour, S; Carpéné, C; Ordener, C; Parini, A; Prévot, D; Valet, P; Visentin, V | 1 |
| Abella, A; Albericio, F; Artuch, R; Bour, S; Brandi, N; Camps, M; Cantó, C; Carpéné, C; García-Barrado, MJ; García-Vicente, S; González-Muñoz, E; Gumà, A; Marti, L; Mian, A; Moratinos, J; Palacín, M; Royo, M; Sierra, C; Testar, X; Yraola, F; Zorzano, A | 1 |
| Halász, AS; Kocsis, E; Magyar, K; Pálfi, M; Soltész, Z; Szökö, E; Tábi, T; Tóth, M | 1 |
| Bour, S; Burcelin, R; Carpéné, C; Fernández-Quintela, A; Grés, S; Iffiú-Soltész', Z; Knauf, C; Lomba, A; Milagro, FI; Prévot, D; Szökö, E | 1 |
| Abella, A; Carpéné, C; Marti, L; Palacín, M; Testar, X; Zorzano, A | 1 |
7 other study(ies) available for benzylamine and Alloxan Diabetes
| Article | Year |
|---|---|
Oral Supplementation with Benzylamine Delays the Onset of Diabetes in Obese and Diabetic db-/- Mice.
Topics: Adipocytes; Amine Oxidase (Copper-Containing); Animals; Benzylamines; Blood Glucose; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Supplements; Eating; Glucose; Humans; Hydrogen Peroxide; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Mice; Mice, Knockout; Mice, Obese; Obesity; Phytochemicals; Receptors, Leptin | 2021 |
Benzylamine exhibits insulin-like effects on glucose disposal, glucose transport, and fat cell lipolysis in rabbits and diabetic mice.
Topics: Adipocytes; Animals; Benzylamines; Biological Transport; Carcinogens; Diabetes Mellitus, Experimental; Drug Interactions; Glucose; Glucose Tolerance Test; Infusions, Intravenous; Insulin; Islets of Langerhans; Lipolysis; Mice; Oxidation-Reduction; Rabbits; Semicarbazides; Starvation | 2004 |
Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
Topics: Adipocytes; Adipose Tissue; Amine Oxidase (Copper-Containing); Animals; Benzylamines; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Glucose; Kidney; Lipolysis; Liver; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Myocardium; Oxidation-Reduction; Pargyline; Rats; Rats, Wistar; Semicarbazides; Tyramine; Vanadates | 2005 |
Oral insulin-mimetic compounds that act independently of insulin.
Topics: Adipocytes; Administration, Oral; Animals; Benzylamines; Diabetes Mellitus, Experimental; Glucose; Hypoglycemic Agents; Injections, Subcutaneous; Insulin Receptor Substrate Proteins; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Oxidative Stress; Phosphoproteins; Phosphorylation; Rats; Rats, Wistar; Streptozocin; Vanadium Compounds | 2007 |
Studies on the insulinomimetic effects of benzylamine, exogenous substrate of semicarbazide-sensitive amine oxidase enzyme in streptozotocin induced diabetic rats.
Topics: Amine Oxidase (Copper-Containing); Animals; Benzylamines; Blood Glucose; Diabetes Mellitus, Experimental; Down-Regulation; Drug Synergism; Drug Therapy, Combination; Glycated Hemoglobin; Glycation End Products, Advanced; Hypoglycemic Agents; Insulin; Male; Nitric Oxide; Rats; Rats, Wistar; Vanadates | 2007 |
Influence of acute and chronic administration of benzylamine on glucose tolerance in diabetic and obese mice fed on very high-fat diet.
Topics: Adipocytes; Animals; Benzylamines; Diabetes Mellitus, Experimental; Dietary Fats; Glucose; Glucose Tolerance Test; Hyperlipidemias; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Obesity; Oxidative Stress | 2007 |
Combined treatment with benzylamine and low dosages of vanadate enhances glucose tolerance and reduces hyperglycemia in streptozotocin-induced diabetic rats.
Topics: Adipocytes; Animals; Benzylamines; Biological Transport; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Glucose; Glucose Intolerance; Glucose Transporter Type 4; Hyperglycemia; Male; Monosaccharide Transport Proteins; Muscle Proteins; Rats; Rats, Wistar; Semicarbazides; Vanadates | 2001 |